Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) 抗体
适用: 小鼠
IHC, WB, IF/ICC
宿主: 小鼠
Monoclonal
S178A-9
unconjugated
1 image
-
- 抗原
- Cav3.1 Ca2+ Channel
- 抗原表位
- AA 2052-2172, C-Term
-
适用
- 小鼠
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- 非结合性
- 应用范围
- Immunohistochemistry (IHC), Western Blotting (WB), Immunofluorescence (fixed cells) (IF/ICC)
- 原理
- Anti-Cav3.1 Ca+2 Channel Mouse Monoclonal Antibody
- 特异性
- This antibody recognizes human, mouse, and rat Cav3.1. It does not cross-react with Cav3.2.
- 交叉反应
- 人, 小鼠, 大鼠
- 交叉反应 （详细）
- No cross Reactivity with Cav3.2
- 纯化方法
- Purified by Protein G affinity chromatography.
- 免疫原
- Fusion protein corresponding to aa 2052-2172 (cytoplasmic C-terminus) of mouse Cav3.1 (accession no. NP_001106284.1).
- 克隆位点
- S178A-9
- 亚型
- IgG1
-
-
- 应用备注
-
Immunoblotting: use at 1-2 μg/mL. A band of >200 kDa is detected.
Immunohistochemistry: use at 1-10 μg/mL.
These are recommended concentrations. User should determine optimal concentrations for their application.
Positive control: Rat brain membranes. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 溶解方式
- Dilute in PBS or medium which is identical to that used in the assay system.
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4, 50 % glycerol, 0.09 % sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- This antibody is stable for at least one (1) year at -20°C.
-
- 抗原
- Cav3.1 Ca2+ Channel
- 别名
- Cav3.1 Ca+2 Channel
- 背景
- Voltage-dependent T-type calcium channel subunit α,Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Cav3.1 is a low-voltage- activated T-type calcium channel expressed throughout the body. Drugs that block T-type calcium channels are used as antihypertensives and antiepileptics and possibly in some anesthetics and antipsychotics.
- NCBI登录号
- NP_001106284
- UniProt
- Q9WUT2
-
You are here:
